In Senegal, the people living with hiv antiretroviral therapy coverage stands at 80%, reflecting an increase of 4% (5.3%) compared to 2021.
People living with HIV antiretroviral therapy coverage in Senegal
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Senegal
Antiretroviral therapy coverage
More indicators for Senegal
Male unintentional poisoning
2.6
0.0
(2019)
Female wasting in children
6.7%
-0.8%
(2019)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar79
+intl dollar3
(2021)
Birth registration
78.7%
+1.9%
(2019)
Contraceptive modern method prevalence
25.5%
+0.1%
(2019)
Senegal Antiretroviral therapy coverage between 2000 and 2022
| Period | Antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 80% | +4% |
| 2021 | 76% | +2% |
| 2020 | 74% | +4% |
| 2019 | 70% | +6% |
| 2018 | 64% | +8% |
| 2017 | 56% | +5% |
| 2016 | 51% | +8% |
| 2015 | 43% | +5% |
| 2014 | 38% | +7% |
| 2013 | 31% | +4% |
| 2012 | 27% | -2% |
| 2011 | 29% | +3% |
| 2010 | 26% | +3% |
| 2009 | 23% | +3% |
| 2008 | 20% | +3% |
| 2007 | 17% | +17% |
| 2006 | 0% | 0% |
| 2005 | 0% | 0% |
| 2004 | 0% | 0% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |